News

Congratulations, Bercin

Congratulations to Bercin, her paper entitled "BIBF 11220 (Nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer" has been accepted to Molecular Cancer Therapeutics.